Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
JAMA Psychiatry|September 8, 2016
Analysis of Intellectual Disability Copy Number Variants for Association With SchizophreniaElliott Rees, Kimberley Kendall, Antonio F Pardiñas, et al.
Molecular Psychiatry|September 21, 2022
Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosisGiorgio Pistis, Javier Vázquez-Bourgon, Margot Fournier, et al.
Schizophrenia Research|September 1, 2023
Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophreniaKira Griffiths, Sophie E Smart, Gareth J Barker, et al.
Schizophrenia Bulletin|January 5, 2021
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant SchizophreniaGrant McQueen, Kyra-Verena Sendt, Amy Gillespie, et al.
Brain, Behavior, and Immunity|October 13, 2023
Changes in immunoglobulin levels during clozapine treatment in schizophreniaKira Griffiths, Maria Ruiz Mellado, Raymond Chung, et al.
Schizophrenia (Heidelberg, Germany)|March 3, 2022
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophreniaFanni Krajner, Laila Hadaya, Grant McQueen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 2022
Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaborationAlice Egerton, Kira Griffiths, Cecila Casetta, et al.
Schizophrenia Research|January 1, 2016
Substance use, medication adherence and outcome one year following a first episode of psychosisMarco Colizzi, Elena Carra, Sara Fraietta, et al.
Psychological Medicine|October 24, 2018
Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 studyEugenia Kravariti, Arsime Demjaha, Jolanta Zanelli, et al.
Pageof 14